| Disease Name |
Pituitary Neoplasms |
| Nocoding RNA Name |
hsa-miR-516b |
| Expression Pattern |
up-regulated |
| Species |
Homo sapiens |
| Detection Methods |
microarray,RT-PCR etc. |
| Target |
N/A |
| Tissue |
brain(pituitary tissues) |
| Treatment |
bromocriptine
|
| PubMed ID |
22366961 |
| Year |
2012 |
| Detail Description |
The initial analysis of microRNA expression data generated a list of 71 microRNAs with a 1.2-fold lower expression in treated prolactinomas compared with untreated tumors, of which 6 microRNAs were downregulated in treated prolactinomas with a P-value <0.1. Inversely, the data also generated a list of 80 microRNAs, with 1.2-fold or higher expression in treated prolactinomas compared with untreated tumors, of which 9 microRNAs were upregulated in treated prolactinomas with a P-value <0.1.qRT-PCR expression analysis for relative expression of 3 specific microRNAs, miR-206, miR-516b and miR-550 were significantly higher in the treated prolactinomas compared to untreated prolactinomas. For another microRNA, miR-671-5p, the relative expression was significantly lower in treated prolactinomas. |
|